• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»preventive diagnostics

20/20 BioLabs and IBM collaboration signals new direction in preventive diagnostics

By Soujanya Ravi on February 26, 2026   Medical Devices & Diagnostics  

20/20 BioLabs and IBM collaboration signals new direction in preventive diagnostics

20/20 BioLabs launches AI-powered OneTest for longevity risk modeling. Discover what this means for preventive diagnostics and regulation.

Why Scilex Holding Company sees strategic optionality in diagnostic platforms beyond traditional therapeutics

By Soujanya Ravi on January 30, 2026   Features & Analysis  

Why Scilex Holding Company sees strategic optionality in diagnostic platforms beyond traditional therapeutics

Explore what Scilex Holding Company’s $20M Quantum Scan investment means for preventive diagnostics and the execution risks ahead.

Can MRI body scans redefine preventive care? AMRA expands into Dutch market with Prescan

By Pallavi Madhiraju on January 11, 2026   Medical Devices & Diagnostics  

Can MRI body scans redefine preventive care? AMRA expands into Dutch market with Prescan

AMRA and Prescan launch a first-in-Netherlands MRI scan to assess fat and muscle composition. Learn how this could redefine early disease detection in Europe.

Recent Posts

  • AACR 2026: SAGA Diagnostics pushes Pathlight MRD deeper into metastatic breast and ovarian cancer
  • Agenus AACR 2026 data show immune reprogramming signal in PD-1 refractory gastroesophageal cancer
  • AACR 2026: Can Zai Lab’s zocilurtatug pelitecan change the treatment picture for small cell lung cancer brain metastases?
  • How JANX014 expands Janux Therapeutics’ tumor-activated platform strategy in prostate cancer immunotherapy
  • What Medicus Pharma Ltd.’s SkinJect application signals for Hedgehog pathway-driven cancers
  • Why Bioxodes’ adaptive trial strategy could accelerate approval timelines in stroke therapeutics
  • What Kura Oncology’s latest data reveals about resistance biology in kidney cancer
  • Can Fate Therapeutics, Inc. solve the conditioning chemotherapy problem in CAR T?
  • Could Ampligen become a late-stage pancreatic cancer breakthrough after AIM ImmunoTech’s latest clinical push?
  • What the new J-code means for Glaukos’ Epioxa launch and the future of keratoconus reimbursement
  • Molgramostim review pushed to November: what Savara’s FDA delay means for autoimmune PAP
  • What SurGenTec’s TiLink navigation clearance means for surgeons using minimally invasive SI joint fusion systems
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes